Adalimumab-induced acute myelogenic leukemia

Southern Medical Journal

Volumn 101, Issue 12, 2008, Pages 1261-1262

  Saba, Nakhle S ^a   Kosseifi, Semaan G ^a   Charaf, Edris A ^a   Hammad, Ahmad N ^a,b  

^a East Tennessee State University   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acute myeloid leukemia; Adalimumab; Alkylating agents; Dysplasia

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; LEFLUNOMIDE; METHOTREXATE; QUININE; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BONE MARROW BIOPSY; BREAST CARCINOMA; CASE REPORT; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 3; DRUG WITHDRAWAL; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MONOSOMY 7; MULTIPLE CYCLE TREATMENT; MYELODYSPLASTIC SYNDROME; OUTCOME ASSESSMENT; PANCYTOPENIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; BIOPSY; BONE MARROW; CHEMICALLY INDUCED DISORDER; FATALITY; HEMATOCRIT; HEMOGLOBIN DETERMINATION; LEUKOCYTE COUNT; PATHOLOGY; THROMBOCYTE COUNT;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; BIOPSY; BONE MARROW; FATAL OUTCOME; FEMALE; HEMATOCRIT; HEMOGLOBINOMETRY; HUMANS; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE COUNT; PLATELET COUNT;

EID: 58149332852     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318188950a     Document Type: Article

References (15)

1. Mease PJ. Adalimumab: an anti-TNF agent for the treatment of psoriatic arthritis. Expert Opin Biol Ther 2005;5:1491-1504.
2. den Broeder A, van de Putte L, Rau R, et al. A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis. J Rheumatol 2002;29:2288-2298.
3. Furst DE, Schiff MH, Fleischmann RM, et al. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). J Rheumatol 2003;30:2563-2571.
4. Bongartz T, Sutton AJ, Sweeting MJ, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006;295:2275-2285.
5. Ziakas PD, Giannouli S, Tzioufas AG, et al. Lymphoma development in a patient receiving anti-TNF therapy. Haematologica 2003;88:ECR25.
6. Scheinfeld N. Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate. J Drugs Dermatol 2006;5:228-231.
7. Brown SL, Greene MH, Gershon SK, et al. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum 2002;46:3151-3158.
8. Smith RE, Bryant J, DeCillis A, et al; National Surgical Adjuvant Breast and Bowel Project Experience. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience. J Clin Oncol 2003;21:1195-1204.
9. Carli PM, Sgro C, Parchin-Geneste N, et al. Increase therapy-related leukemia secondary to breast cancer. Leukemia 2000;14:1014-1017.
10. Curtis RE, Boice JD Jr, Stovall M, et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 1992;326:1745-1751.
11. Briasoulis E, Tzouvara E, Tsiara S, et al. Biphenotypic acute leukemia following intensive adjuvant chemotherapy for breast cancer: case report and review of the literature. Breast J 2003;9:241-245.
12. Ando M, Narabayashi M, Watanabe T, et al. Therapy-related leukemia and myelodysplastic syndrome in breast cancer patients treated with cyclophosphamide or anthracyclines. Jpn J Clin Oncol 1999;29:28-32.
13. Chaplain G, Milan C, Sgro C, et al. Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study. J Clin Oncol 2000;18:2836-2842.
14. Jang GD, Kim SW, Suh CW, et al. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma. J Korean Med Sci 2002;17:555-559.
15. Ng A, Taylor GM, Eden OB. Treatment-related leukaemia - a clinical and scientific challenge. Cancer Treat Rev 2000;26:377-391